SCHEMBL29388237

SCHEMBL29388237

O=C(O)c1cc(NCCCc2ccc([N+](=O)[O-])cc2)ccc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
MAPT P10636 4/20 0.58
KMT2A Q03164 2/20 0.58
NPC1 O15118 2/20 0.58
MEN1 O00255 1/20 0.58
TRPA1 O75762 1/20 0.58
LMNA P02545 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
TSHR P16473 1/20 0.58
CDK2 P24941 1/20 0.58
MAPK1 P28482 1/20 0.58
THPO P40225 1/20 0.58
BLM P54132 1/20 0.58
PMP22 Q01453 1/20 0.58
HSD17B10 Q99714 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
LDHA P00338 2/20 0.51
LDHB P07195 1/20 0.51
HAO1 Q9UJM8 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL609849 1.00 ALDH1A1 (0.58) ALDH1A1MAPTKMT2ANPC1MEN1
SCHEMBL29390925 0.93 MAPT (0.56) ALDH1A1MAPTKMT2ANPC1MEN1
SCHEMBL609284 0.93 MAPT (0.56) ALDH1A1MAPTKMT2ANPC1MEN1
SCHEMBL29388556 0.85 KDM4C (0.67) ALDH1A1MAPTKMT2AMEN1LDHA
SCHEMBL611465 0.85 KDM4C (0.67) ALDH1A1MAPTKMT2AMEN1LDHA
SCHEMBL29390491 0.84 PPARA (0.68) ALDH1A1MAPTKMT2ANPC1TDP1
SCHEMBL607642 0.84 PPARA (0.68) ALDH1A1MAPTKMT2ANPC1TDP1
SCHEMBL610427 0.83 SYK (0.59) ALDH1A1MAPTKMT2ANPC1MEN1
SCHEMBL608860 0.83 MCL1 (0.58) ALDH1A1MAPTCYP1A2CYP2C9TSHR
SCHEMBL12086223 0.81 LCK (0.64) ALDH1A1MAPTKMT2ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114096227-A Cosmetic compositions comprising 5-benzylaminosalicylic acid derivatives and methods of topical use thereof 吉恩特药业株式会社 2022-02-25 CN claimed
US-20250255844-A1 COMPOSITIONS AND METHODS FOR TREATING PULMONARY DISORDERS GNT PHARMA CO., LTD. (KR) 2025-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250255844-A1 COMPOSITIONS AND METHODS FOR TREATING PULMONARY DISORDERS HAO2, ACOX1, HAO1 ALDH1A1 309/4885MAPT 3976/4885KMT2A 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.